EUVIMEDEUVIMED entdecken
Open Access

miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling

Shruti Rawal, Vinay Randhawa, Syed Husain Mustafa Rizvi, Madhur Sachan, Akm Khyrul Wara, Daniel Pérez-Cremades, Robert M Weisbrod, Naomi M Hamburg, Mark W Feinberg iD

Cardiovascular Research · 25.11.2024 · 120 (14) · 1693-1712

DOI: 10.1093/cvr/cvae102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 04.05.2024. Verfasst von Shruti Rawal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: MicroRNAs, Receptors, G-Protein-Coupled, Macrophages, Signal Transduction. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Diabetes leads to dysregulated macrophage immunometabolism, contributing to accelerated atherosclerosis progression. Identifying critical factors to restore metabolic alterations and promote resolution of inflammation remains an unmet goal. MicroRNAs orchestrate multiple signalling events in macrophages, yet their therapeutic potential in diabetes-associated atherosclerosis remains unclear. Methods and results miRNA profiling revealed significantly lower miR-369-3p expression in aortic intimal lesions from Ldlr–/– mice on a high-fat sucrose-containing (HFSC) diet for 12 weeks. miR-369-3p was also reduced in peripheral blood mononuclear cells from diabetic patients with coronary artery disease (CAD). Cell-type expression profiling showed miR-369-3p enrichment in aortic macrophages. In vitro, oxLDL treatment reduced miR-369-3p expression in mouse bone marrow-derived macrophages (BMDMs). Metabolic profiling in BMDMs revealed that miR-369-3p overexpression blocked the oxidized low density lipoprotein (oxLDL)-mediated increase in the cellular metabolite succinate and reduced mitochondrial respiration (OXPHOS) and inflammation [Interleukin (lL)-1β, TNF-α, and IL-6]. Mechanistically, miR-369-3p targeted the succinate receptor (GPR91) and alleviated the oxLDL-induced activation of inflammasome signalling pathways. Therapeutic administration of miR-369-3p mimics in HFSC-fed Ldlr−/− mice reduced GPR91 expression in lesional macrophages and diabetes-accelerated atherosclerosis, evident by a decrease in plaque size and pro-inflammatory Ly6Chi monocytes. RNA-Seq analyses showed more pro-resolving pathways in plaque macrophages from miR-369-3p-treated mice, consistent with an increase in macrophage efferocytosis in lesions. Finally, a GPR91 antagonist attenuated oxLDL-induced inflammation in primary monocytes from human subjects with diabetes.

Conclusion

These findings establish a therapeutic role for miR-369-3p in halting diabetes-associated atherosclerosis by regulating GPR91 and macrophage succinate metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsReceptors, G-Protein-CoupledMacrophagesSignal TransductionMice, KnockoutAtherosclerosisMice, Inbred C57BLDisease Models, AnimalLipoproteins, LDLSuccinic AcidAnimalsHumansMalePlaque, AtheroscleroticMiceReceptors, LDLAortic DiseasesCells, CulturedGene Expression RegulationDiabetic AngiopathiesFemaleMiddle Aged

Stichwörter der Autor:innen

AtherosclerosisDiabetesGPR91MacrophageSuccinatemicroRNA

Substanzen

MicroRNAsReceptors, G-Protein-CoupledGPR91 protein, mouseoxidized low density lipoproteinSUCNR1 protein, humanLipoproteins, LDLSuccinic AcidReceptors, LDL

Autor:innen und Institutionen

  • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
  • Vascular Biology Section, Boston University School of Medicine, Boston, MA, USA.
  • Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
  • Department of Physiology, University of Valencia, INCLIVA Biomedical Research Institute, Valencia 46010, Spain.

ORCID-Profile: Mark W Feinberg

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • American Heart Association
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Rawal, S., Randhawa, V., Rizvi, S. H. M., Sachan, M., Wara, A. K., Pérez-Cremades, D., Weisbrod, R. M., Hamburg, N. M., & Feinberg, M. W. (2024). miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling. Cardiovascular Research, 120(14), 1693-1712. https://doi.org/10.1093/cvr/cvae102

Vancouver

Rawal S, Randhawa V, Rizvi SHM, Sachan M, Wara AK, Pérez-Cremades D, et al. miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling. Cardiovascular Research. 2024;120(14):1693-1712. doi:10.1093/cvr/cvae102

BibTeX
@article{Rawal2024,
  author = {Rawal, Shruti and Randhawa, Vinay and Rizvi, Syed Husain Mustafa and Sachan, Madhur and Wara, Akm Khyrul and Pérez-Cremades, Daniel and Weisbrod, Robert M and Hamburg, Naomi M and Feinberg, Mark W},
  title = {miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {14},
  pages = {1693--1712},
  doi = {10.1093/cvr/cvae102}
}
Kostenlos starten →